Paragraph 1
In the Medicines (Pharmacy and General Sale Exemption) Order 1980f1 in article 1 (citation, commencement and interpretation), in paragraph (2)—
in the definition of “Community marketing authorization” after “Regulation (EEC) No. 2309/93” insert “or Regulation (EC) No. 726/2004 of the European Parliament and of the Council laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency”,
after the definition of “cosmetic” insert the following definition—
““Directive 2001/83/EC” means Directive 2001/83/EC of the European Parliament and of the Council on the Community code relating to medicinal products for human use as amended by Directive 2002/98/EC of the European Parliament and of the Council setting standards of quality and safety for the collection, testing, processing, storage and distribution of human blood and blood componentsf2, Commission Directive 2003/63/EC amending Directive 2001/83/EC on the Community code relating to medicinal products for human use, Directive 2004/24/EC of the European Parliament and of the Council amending, as regards traditional herbal medicinal products, Directive 2001/83/EC on the Community code relating to medicinal products for human use and Directive 2004/27/EC of the European Parliament and of the Council amending Directive 2001/83/EC on the Community code relating to medicinal products for human use”, and
in the definition of “United Kingdom marketing authorization” after “Schedule 6 to those Regulations” insert “or an authorization granted by the licensing authority in accordance with Article 126a of Directive 2001/83/EC”.
Annotations
Footnotes
- f1
-
S.I. 1980/1924; relevant amending instrument is S.I. 2000/1919.
- f2
-
OJ No. L33, 8.2.2003, p.30.